Clinical Trial Update: Study to Evaluate the Safety and Efficacy of PAZ320 in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of PAZ320 in insulin-treated Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PAZ320

Snippet

Sponsor: Boston Therapeutics | Conditions: Type 2 Diabetes Treated With Insulin | Phase 2 | Status: COMPLETED